EUCTR2012-000147-27-GB
Active, not recruiting
Not Applicable
A Single-Blind Randomised Controlled Pilot trial of Corticosteroid Injection for Shoulder Pain - Pilot Trial of Steroid Injection for Shoulder Pain (RCT2), Version 1
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Rotator cuff tendinopathyAdhesive capsulitis of the shoulder joint
- Sponsor
- niversity of Oxford
- Status
- Active, not recruiting
- Last Updated
- 12 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male or female, aged 35 to 74 years
- •Diagnosed with rotator cuff tendinopathy or adhesive capsulitis by a general practitioner trained in shoulder assessment, with duration of symptoms no greater than 6 months
- •Willing to allow his or her usual General Practitioner to be notified of participation in the study and to be contacted for further information if an adverse event related to the trial occurs
- •Able to complete follow\-up data collection by questionnaire at 2, 4 and 12 weeks
- •Willing and able to give informed consent for participation in the trial
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 35
- •F.1\.3 Elderly (\>\=65 years) yes
Exclusion Criteria
- •Female participants who are pregnant, lactating or planning pregnancy during the course of the study
- •Participants who have participated in another research study involving an investigational product in the past 12 weeks
- •Those having already received a shoulder injection in the past 12 months
- •Those with other established chronic shoulder disorders (e.g. rheumatoid arthritis, other inflammatory poly\-arthropathies and osteroarthritis)
- •A history of previous shoulder surgery on the affected side
- •Those with evidence of active infection anywhere, including temperature \= to or \> than 37\.5oC
- •Those currently prescribed anticoagulants
- •Those either currently prescribed or likely to need during the following 12 months, systemic corticosteroids for any reason
- •Immunocompromised
- •Uncontrolled diabetes or uncontrolled hypertension
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Pilot trial of steroid injection for shoulder paiISRCTN82357435niversity of Oxford (UK)50
Completed
Not Applicable
A randomised, controlled, single blind pilot study to evaluate the efficacy of a mindfulness stress reduction intervention as an adjunct therapy in moderate to severe psoriasisISRCTN51850035Department of Health50
Not yet recruiting
Not Applicable
A clinical trial to study the effects and safety of 3 drugs in varied combinations, namely 1% Luliconazole cream plus 1% Ciclopirox Olamine cream, 1% Luliconazole cream plus 0.25% Amorolfine cream and 1% Luliconazole cream alone in the treatment of ringworm, a fungal infection of skin.Health Condition 1: B354- Tinea corporisCTRI/2022/12/048431SRM Medical College Hospital & Research Centre, SRMIST, Potheri
Completed
Not Applicable
Improving communication between health care professionals to help patients avoid unnecessary hospital visits.ACTRN12609000554268The University of Sydney500
Completed
Not Applicable
A single-blind randomized controlled trial of AVS023 poly-herbal formula for Acute low back pain: a pilot studyAcute low back pain patientacute Low Back Pain (LBP)anti-inflammatory,analgesicsAVS023 poly-herbal formula (Ayurved Siriraj Sahatsatara recipe)ibuprofenTCTR20141027001Faculty of Medicine Siriraj Hospital29